USPTO issues notice of allowance for Avanir Nuedexta patent
The patent application entitled, Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders, claims methods for treating pseudobulbar affect or emotional lability using low-dose quinidine
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.